Skip to main content
Thomas Keane, MD, Urology, Charleston, SC, MUSC Health University Medical Center

ThomasEKeaneMD

Urology Charleston, SC

Surgical Oncology

Professor of Urology, Chairman of Department. Medical University of South Carolina.

Dr. Keane is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Keane's full profile

Already have an account?

Summary

  • Chairman of the department of urology since 2002
    Expanded the faculty from 4 to 14 attendings, and the residency from 6 to 15 residents, Established 2 Fellowships: Female pelvic health and reconstruction and Advanced oncologic surgical training.
    Established 3 endowed chairs and multiple funded research Grants.

Education & Training

  • Duke University Hospital
    Duke University HospitalResidency, Urology, 1988 - 1993
  •  Surgical fellowship training scheme
    Surgical fellowship training schemeFellow of the Royal R College Surgeons In Ireland., General Surgery, 1983 - 1986
  • University College of Dublin National Univ SOM
    University College of Dublin National Univ SOMClass of 1981

Certifications & Licensure

  • SC State Medical License
    SC State Medical License 2002 - 2025
  • FL State Medical License
    FL State Medical License 2013 - 2019
  • GA State Medical License
    GA State Medical License 1993 - 2009
  • NC State Medical License
    NC State Medical License 1989 - 1993
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Member of the Academic Association of European urologists EAU.
  • editor of 5th,6th,7th and 8th editions of Glenns Urologic Surgery -Textbook
  • America's Top Doctor US News and World Report
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Precision Incisions: Minimally Invasive Techniques in Genitourinary Cancer
    Precision Incisions: Minimally Invasive Techniques in Genitourinary CancerOctober 15th, 2019
  • RADAR II Group Recommendations - the Role of Therapeutic Layering
    RADAR II Group Recommendations - the Role of Therapeutic LayeringMay 23rd, 2018
  • Discussion of the IMmotion 151 Trial: Atezolizumab plus Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma - Thomas Keane
    Discussion of the IMmotion 151 Trial: Atezolizumab plus Bevacizumab vs Sunitinib in Untreated Metastatic Renal Cell Carcinoma - Thomas KeaneJune 6th, 2020

Professional Memberships

Hospital Affiliations